These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 27134306)

  • 1. Multi-Targeted Antithrombotic Therapy for Total Artificial Heart Device Patients.
    Ramirez A; Riley JB; Joyce LD
    J Extra Corpor Technol; 2016 Mar; 48(1):27-34. PubMed ID: 27134306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombotic therapy for the CardioWest temporary total artificial heart.
    Ensor CR; Cahoon WD; Crouch MA; Katlaps GJ; Hess ML; Cooke RH; Gunnerson KJ; Kasirajan V
    Tex Heart Inst J; 2010; 37(2):149-58. PubMed ID: 20401285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aprotinin shows both hemostatic and antithrombotic effects during off-pump coronary artery bypass grafting.
    Poston RS; White C; Gu J; Brown J; Gammie J; Pierson RN; Lee A; Connerney I; Avari T; Christenson R; Tandry U; Griffith BP
    Ann Thorac Surg; 2006 Jan; 81(1):104-10; discussion 110-1. PubMed ID: 16368345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Thromboelastography Platelet Mapping and International Normalized Ratio in Defining "Normocoagulability" During Anticoagulation for Mechanical Circulatory Support Devices: A Pilot Retrospective Study.
    Volod O; Lam LD; Lin G; Kam C; Kolyouthapong K; Mac J; Mirocha J; Ambrose PJ; Czer LS; Arabia FA
    ASAIO J; 2017; 63(1):24-31. PubMed ID: 27660902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of bleeding risk of interventional techniques: a best evidence synthesis of practice patterns and perioperative management of anticoagulant and antithrombotic therapy.
    Manchikanti L; Falco FJ; Benyamin RM; Caraway DL; Kaye AD; Helm S; Wargo BW; Hansen H; Parr AT; Singh V; Swicegood JR; Smith HS; Schultz DM; Malla Y; Hirsch JA
    Pain Physician; 2013 Apr; 16(2 Suppl):SE261-318. PubMed ID: 23615893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of antithrombotic therapy in patients undergoing electrophysiological device surgery.
    Zacà V; Marcucci R; Parodi G; Limbruno U; Notarstefano P; Pieragnoli P; Di Cori A; Bongiorni MG; Casolo G
    Europace; 2015 Jun; 17(6):840-54. PubMed ID: 25712980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results with an anticoagulation protocol in 99 SynCardia total artificial heart recipients.
    Copeland J; Copeland H; Nolan P; Gustafson M; Slepian M; Smith R
    ASAIO J; 2013; 59(3):216-20. PubMed ID: 23644607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
    Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
    Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control and treatment of hemostasis in cardiovascular surgery. The experience of La Pitié Hospital with patients on total artificial heart.
    Szefner J
    Int J Artif Organs; 1995 Oct; 18(10):633-48. PubMed ID: 8647597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of two individualized antithrombotic protocols in HeartWare HVAD recipients.
    Sorensen EN; Plazak ME; Dees LM; Klass WJ; Ziegler LA; Ledroux SN; Griffith BP; Feller ED
    Artif Organs; 2022 Jan; 46(1):117-127. PubMed ID: 34425001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population-based evaluation of the management of antithrombotic therapy for atrial fibrillation.
    Anderson DR; Gardner MJ; Putnam W; Jassal D; Brownell B; Flowerdew G; Nagpal S; Thompson K; Cox JL
    Can J Cardiol; 2005 Mar; 21(3):257-66. PubMed ID: 15776115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Animal studies with the Carmat bioprosthetic total artificial heart.
    Latrémouille C; Duveau D; Cholley B; Zilberstein L; Belbis G; Boughenou MF; Meleard D; Bruneval P; Adam C; Neuschwander A; Perles JC; Jansen P; Carpentier A
    Eur J Cardiothorac Surg; 2015 May; 47(5):e172-8; discussion e178-9. PubMed ID: 25719178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results with SynCardia total artificial heart beyond 1 year.
    Torregrossa G; Morshuis M; Varghese R; Hosseinian L; Vida V; Tarzia V; Loforte A; Duveau D; Arabia F; Leprince P; Kasirajan V; Beyersdorf F; Musumeci F; Hetzer R; Krabatsch T; Gummert J; Copeland J; Gerosa G
    ASAIO J; 2014; 60(6):626-34. PubMed ID: 25158888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of late bleeding following hemorrhoidal banding in patients on antithrombotic prophylaxis.
    Nelson RS; Ewing BM; Ternent C; Shashidharan M; Blatchford GJ; Thorson AG
    Am J Surg; 2008 Dec; 196(6):994-9; discussion 999. PubMed ID: 19095121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The challenge of home discharge with a total artificial heart: the La Pitie Salpetriere experience.
    Demondion P; Fournel L; Niculescu M; Pavie A; Leprince P
    Eur J Cardiothorac Surg; 2013 Nov; 44(5):843-8. PubMed ID: 23539421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First clinical use of a bioprosthetic total artificial heart: report of two cases.
    Carpentier A; Latrémouille C; Cholley B; Smadja DM; Roussel JC; Boissier E; Trochu JN; Gueffet JP; Treillot M; Bizouarn P; Méléard D; Boughenou MF; Ponzio O; Grimmé M; Capel A; Jansen P; Hagège A; Desnos M; Fabiani JN; Duveau D
    Lancet; 2015 Oct; 386(10003):1556-63. PubMed ID: 26231456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late Surgical Bleeding Following Total Artificial Heart Implantation.
    Hermsen JL; Smith JW; Pal JD; Mahr C; Masri SC; Dardas TF; Cheng RK; Mokadam NA
    J Card Surg; 2015 Oct; 30(10):771-4. PubMed ID: 26286927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implantation of cardiac rhythm devices during concomitant anticoagulation or antiplatelet therapy.
    Ramirez A; Wall TS; Schmidt M; Selzman K; Daccarett M
    Expert Rev Cardiovasc Ther; 2011 May; 9(5):609-14. PubMed ID: 21615324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
    Douketis JD; Johnson JA; Turpie AG
    Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.